P-603 Phase I results of RTOG L-0117; a phase i/II dose intensificationstudy using 3DCRT and concurrent chemotherapy for patients with inoperable NSCLC

Authors :: Jack F. Fowler
E. Gore
Jeffrey D. Bradley
Mary V. Graham
R. Byhardt
James A. Purdy
Hak Choy
J. Michalski
S. Swann
Ramaswamy Govindan
Source :: Lung Cancer. 49:S277
Publication Year :: 2005
Publisher :: Elsevier BV, 2005.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
Cancer Research
medicine.medical_specialty
Concurrent chemotherapy
Phase i ii
business.industry
Internal medicine
Phase (matter)
medicine
business

Full Text Access

Tools